| Genomics of rare genetic diseases—experiences from India S Sivasubbu, V Scaria Human genomics 13 (1), 52, 2019 | 65 | 2019 |
| A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19 Y Ray, SR Paul, P Bandopadhyay, R D’Rozario, J Sarif, D Raychaudhuri, ... Nature Communications 13 (1), 383, 2022 | 36 | 2022 |
| Genetics of ataxias in Indian population: a collative insight from a common genetic screening tool P Sharma, AK Sonakar, N Tyagi, V Suroliya, M Kumar, R Kutum, ... Advanced Genetics 3 (2), 2100078, 2022 | 12 | 2022 |
| Vaccine breakthrough infections by SARS-CoV-2 variants after ChAdOx1 nCoV-19 vaccination in healthcare workers P Kale, E Gupta, C Bihari, N Patel, S Rooge, A Pandey, M Bajpai, ... Vaccines 10 (1), 54, 2021 | 10 | 2021 |
| Single-cell multiomics revealed the dynamics of antigen presentation, immune response and T cell activation in the COVID-19 positive and recovered individuals P Chattopadhyay, K Khare, M Kumar, P Mishra, A Anand, R Maurya, ... Frontiers in Immunology 13, 1034159, 2022 | 9 | 2022 |
| Adhatoda vasica and Tinospora cordifolia extracts ameliorate clinical and molecular markers in mild COVID-19 patients: a randomized open-label three-armed study M Verma, N Rawat, R Rani, M Singh, A Choudhary, S Abbasi, M Kumar, ... European Journal of Medical Research 28 (1), 556, 2023 | 4 | 2023 |
| The molecular mechanisms of spinocerebellar ataxias for DNA repeat expansion in disease M Kumar, N Tyagi, M Faruq Emerging Topics in Life Sciences 7 (3), 289-312, 2023 | 3 | 2023 |
| Generation of induced pluripotent stem cell line (IGIBi007-A) from a patient with a novel acromesomelic dysplasia, PRKG2 type (AMDP) M Kumar, S Wadhwa, N Tyagi, I Ahmad, S Kumar, S Sagar, S Zahra, ... Stem Cell Research 53, 102340, 2021 | 2 | 2021 |
| Molecular Clues Unveiling Spinocerebellar Ataxia Type 12 Pathogenesis M Kumar, S Sahni, A Vivekanand, D Goel, H Kapoor, AK Srivastava, ... iScience, 2024 | | 2024 |
